Stroke Patients Lose Month for Each 15-Minute Delay

Stroke Patients Lose Month for Each 15-Minute Delay

Stroke patients are robbed of a month of disability-free life for every 15-minute delay in treatment to restore blood flow to the brain, a study found.

The clot-busting therapy tissue plasminogen activator, or tPA, should be given within 4 and a half hours of the onset of stroke symptoms, according to the American Stroke Association. Speeding treatment by just 1 minute means another 1.8 days of healthy life, according to research published today in the journal Stroke by doctors in Australia, Finland and the U.S.

“The main delay in stroke is due to people not calling for help,” said lead author Atte Meretoja, an associate professor of medicine at the University of Melbourne and a neurologist at the Royal Melbourne Hospital. “We have now demonstrated that this is very harmful, and people lose on average a month of life for every 15 minutes they wait at home hoping that the symptoms will go away.”

By quantifying the importance of speed, the researchers aim to inspire medical services to improve response time. The world’s fastest stroke services in Helsinki and Melbourne take an average 20 minutes from the patient’s arrival at the hospital to start treatment, Meretoja said. Most other centers in Australia, the U.S. and Europe take 70-80 minutes.

Brain Death

Stroke is the fourth-most common cause of death in the U.S, and the leading cause of adult disability. It occurs when blood flow to the brain stops, according to the U.S. National Institutes of Health. Brain cells begin to die within minutes. Ischemic stroke, which accounts for about 87 percent of cases, is caused by a blood clot, while hemorrhagic stroke is caused by a blood vessel that breaks and bleeds into the brain.

Symptoms of stroke include sudden numbness of the leg, arm or face, confusion, problems with vision, abrupt severe headache, dizziness, loss of balance or trouble walking. The American Stroke Association advises that people call emergency medical services immediately if someone shows any of these symptoms.

The research by scientists at the University of Melbourne, Helsinki University Central Hospital and the University of California, Los Angeles Stroke Center, is based on evidence from trials of clot-busting drugs that was applied to 2,258 stroke patients in Australia and Finland to calculate what the patient outcomes would have been if they had been treated faster or slower.

Although all patients benefited from faster treatment, younger patients with longer life expectancies gained more than older patients, the authors found.

To contact the reporter on this story: Jason Gale in Melbourne at j.gale@bloomberg.net

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment